About BCAL Diagnostics
BCAL Diagnostics is commercialising a simple blood test to detect breast cancer earlier and more accurately. The BCAL Dx approach could revolutionise detection of breast cancer as the technology enables accessibility to a routine method of screening for women of all ages and has multiple applications in screening, diagnostics, treatment and monitoring.
Initial studies have demonstrated 90% sensitivity and specificity in the detection of invasive ductal carcinoma, the most common form of invasive breast cancer. BCAL Dx is focused on finalising the development of this screening test for commercial use, in order to commence clinical trials.